@saifsrathore @ADAlthousePhD Here's a link to the paper, in case anyone is interested (4/4)... https://t.co/agNZgvKeHV
RT @JACCJournals: #TAVR in patients with LVEF under 30% reduces hospitalizations – but what about everyone else? Find out in #JACC. https:/…
RT @JACCJournals: Can #TAVR help reduce hospitalizations for patients with severe aortic stenosis? See the results in #JACC: https://t.co/0…
RT @JACCJournals: Can #TAVR help reduce hospitalizations for patients with severe aortic stenosis? See the results in #JACC: https://t.co/0…
RT @JACCJournals: Can #TAVR help reduce hospitalizations for patients with severe aortic stenosis? See the results in #JACC: https://t.co/0…
RT @JACCJournals: Do you think #TAVR reduces hospitalizations in patients with severe AS? https://t.co/wFJpVUaZMc #JACC @DCRINews
RT @JACCJournals: Do you think #TAVR reduces hospitalizations in patients with severe AS? https://t.co/wFJpVUaZMc #JACC @DCRINews
Do you think #TAVR reduces hospitalizations in patients with severe AS? https://t.co/wFJpVUaZMc #JACC @DCRINews
RT @djc795: Congratulations to Sreek Vemulapalli, Suzanne Baron, and co-authors for this important contribution to our understanding of the…
RT @JACCJournals: Can #TAVR help reduce hospitalizations for patients with severe aortic stenosis? See the results in #JACC: https://t.co/0…
RT @JACCJournals: Can #TAVR help reduce hospitalizations for patients with severe aortic stenosis? See the results in #JACC: https://t.co/0…
RT @JACCJournals: Can #TAVR help reduce hospitalizations for patients with severe aortic stenosis? See the results in #JACC: https://t.co/0…
RT @JACCJournals: Can #TAVR help reduce hospitalizations for patients with severe aortic stenosis? See the results in #JACC: https://t.co/0…
RT @JACCJournals: Can #TAVR help reduce hospitalizations for patients with severe aortic stenosis? See the results in #JACC: https://t.co/0…
RT @JACCJournals: #TAVR in patients with LVEF under 30% reduces hospitalizations – but what about everyone else? Find out in #JACC. https:/…
RT @JACCJournals: Can #TAVR help reduce hospitalizations for patients with severe aortic stenosis? See the results in #JACC: https://t.co/0…
RT @JACCJournals: Can #TAVR help reduce hospitalizations for patients with severe aortic stenosis? See the results in #JACC: https://t.co/0…
RT @JACCJournals: Can #TAVR help reduce hospitalizations for patients with severe aortic stenosis? See the results in #JACC: https://t.co/0…
RT @JACCJournals: Can #TAVR help reduce hospitalizations for patients with severe aortic stenosis? See the results in #JACC: https://t.co/0…
RT @JACCJournals: Can #TAVR help reduce hospitalizations for patients with severe aortic stenosis? See the results in #JACC: https://t.co/0…
Can #TAVR help reduce hospitalizations for patients with severe aortic stenosis? See the results in #JACC: https://t.co/0Te9nah47E @DCRINews #vhdAS https://t.co/feksdunoq8
RT @JACCJournals: #TAVR in patients with LVEF under 30% reduces hospitalizations – but what about everyone else? Find out in #JACC. https:/…
RT @djc795: Congratulations to Sreek Vemulapalli, Suzanne Baron, and co-authors for this important contribution to our understanding of the…
RT @JACCJournals: #TAVR in patients with LVEF under 30% reduces hospitalizations – but what about everyone else? Find out in #JACC. https:/…
RT @djc795: Congratulations to Sreek Vemulapalli, Suzanne Baron, and co-authors for this important contribution to our understanding of the…
RT @djc795: Congratulations to Sreek Vemulapalli, Suzanne Baron, and co-authors for this important contribution to our understanding of the…
RT @JACCJournals: #TAVR in patients with LVEF under 30% reduces hospitalizations – but what about everyone else? Find out in #JACC. https:/…
RT @djc795: Congratulations to Sreek Vemulapalli, Suzanne Baron, and co-authors for this important contribution to our understanding of the…
RT @djc795: Congratulations to Sreek Vemulapalli, Suzanne Baron, and co-authors for this important contribution to our understanding of the…
RT @djc795: Congratulations to Sreek Vemulapalli, Suzanne Baron, and co-authors for this important contribution to our understanding of the…
RT @JACCJournals: #TAVR in patients with LVEF under 30% reduces hospitalizations – but what about everyone else? Find out in #JACC. https:/…
RT @JACCJournals: #TAVR in patients with LVEF under 30% reduces hospitalizations – but what about everyone else? Find out in #JACC. https:/…
RT @JACCJournals: #TAVR in patients with LVEF under 30% reduces hospitalizations – but what about everyone else? Find out in #JACC. https:/…
RT @djc795: Congratulations to Sreek Vemulapalli, Suzanne Baron, and co-authors for this important contribution to our understanding of the…
RT @djc795: Congratulations to Sreek Vemulapalli, Suzanne Baron, and co-authors for this important contribution to our understanding of the…
Congratulations to Sreek Vemulapalli, Suzanne Baron, and co-authors for this important contribution to our understanding of the benefits (and limitations) of TAVR for reducing healthcare costs. @DCRINews @MidAmericaHeart
RT @JACCJournals: #TAVR in patients with LVEF under 30% reduces hospitalizations – but what about everyone else? Find out in #JACC. https:/…
RT @JACCJournals: #TAVR in patients with LVEF under 30% reduces hospitalizations – but what about everyone else? Find out in #JACC. https:/…
#TAVR in patients with LVEF under 30% reduces hospitalizations – but what about everyone else? Find out in #JACC. https://t.co/135MscIFGV @DCRINews https://t.co/fhSMK3UZjs